RespireRx Pharmaceuticals Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From RespireRx Pharmaceuticals Inc.
The European Medicine Agency has recommended extending the therapeutic indication of a raft of drugs that are already authorized in the EU.
The Ascyrus Medical Dissection Stent is designed to help remodel the aortic arch following an aortic dissection. CryoLife will pay up to $200m for Ascyrus.
Takeda’s collaboration with the private UK biotech includes NASH and other liver disorders. Reliance will take on Amazon in the India pharmacy space with acquisition of Netmeds.
Amazon Pharmacy’s debut in India could recalibrate and disrupt drug dispensing and distribution in the country, while also tempering investment flow in the e-pharmacy segment. Some experts also predict a squeeze on pharma’s profits.
- Other Names / Subsidiaries
- Cortex Pharmaceuticals, Inc.
- Pier Pharmaceuticals, Inc.